CENTER FOR BIOMEDICAL RESEARCH AND DEVELOPMENT
Area: Incubation
Booth No: N416
Website: https://web.ncku.edu.tw
Exhibitor Profile
Protein Modification Platform: Enhances the stability of therapeutics using disulfide bonds, HSA/Fc fusions, and PEGylation.
Engineered IL-2 Cytokine: 2-fold activity and a 25°C increase in thermal stability.
Bispecific Anticancer Drugs: targeting integrin and VEGF pathways to treat cancers.
Antithrombotic & Thrombolytic Agents: novel therapies minimizing bleeding and thrombocytopenia.
Advanced Lactate Oxidase: 11.7-fold higher solubility and 50% acid resistance for the sensing patch.
Brands
Production and Modification Platforms for Protein Therapeutics
Exhibit Products
-
Protein Production and GLP Laboratory
-
Modification Platforms for Protein Therapeutics
-
Anti-fibrotic Drug Targeting ECM
-
Bispecific Drugs for Cancers
-
Fibrin and Platelet-targeting Thrombolytic Drug
-
Antithrombotic Drug with Low Risk of Bleeding
Exhibitors you may be interested in
Highest Rated